Title: | Clinical Medication Guidelines for Glaucoma |
Edition: | Original |
Classification: | Standard guideline |
Field: | Treatment |
Countries and regions: | China |
Guidelines users: | Ophthalmologist, pharmacist and nurse |
Evidence classification method: | GRADE system |
Development unit: | the Chinese Pharmaceutical Association, Hospital Pharmacy Professional Committee; the Chinese Pharmaceutical Association, Evidence-based Pharmacy Professional Committee; Peking University Third Hospital; Institute for drug evaluation, Peking University Health Science Center |
Registration time: | 2021-01-15 |
Registration number: | IPGRP-2021CN009 |
Purpose of the guideline: | Based on the method of evidence-based pharmacy, this guideline aims to integrate the resources and strength of ophthalmology pharmacy, summarize the best evidence available for clinical medication of glaucoma patients, and provide appropriate recommendations for clinical medication of glaucoma patients combined with physicians' experience and patients' preference. |
Latest registration